BioMarin’s Future Plans ◗ Investigational studies. BioMarin will begin conducting a long-term study to assess the impact of Kuvan on neurocognitive function in children with PKU, 0 to 8 years of age. BioMarin is also

Source URL: www.pkunews.org

• Pharmacology
• Mental retardation
• Phenylketonuria
• Tetrahydrobiopterin
• BioMarin Pharmaceutical
• Food and Drug Administration
• Clinical trial
• Orlistat
• Lofenalac
• Health
• Chemistry
• Medicine